Related Experiment Video
Updated: Mar 1, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Factor H Family Proteins in Complement Evasion of Microorganisms
1MTA-ELTE "Lendület" Complement Research Group, Department of Immunology, Eötvös Loránd University, Budapest, Hungary.
Abstract:
Human-pathogenic microbes possess various means to avoid destruction by our immune system. These include interactions with the host complement system that may facilitate pathogen entry into cells and tissues, expression of molecules that defuse the effector complement components and complexes, and acquisition of host complement inhibitors to downregulate complement activity on the surface of the pathogen. A growing number of pathogenic microorganisms have acquired the ability to bind the complement inhibitor factor H (FH) from body fluids and thus hijack its host protecting function. In addition to FH, binding of FH-related (FHR) proteins was also demonstrated for several microbes. Initial studies assumed that these proteins are complement inhibitors similar to FH. However, recent evidence suggests that FHR proteins may rather enhance complement activation both directly and also by competing with the inhibitor FH for binding to certain ligands and surfaces. This mini review focuses on the role of the main alternative pathway regulator FH in host-pathogen interactions, as well as on the emerging role of the FHR proteins as enhancers of complement activation.
Insights
Pathogenic microbes evade immune defenses by manipulating the complement system. While factor H (FH) inhibits complement, FH-related (FHR) proteins may unexpectedly enhance it, aiding pathogen survival.
Area of Science:
- Immunology
- Microbiology
- Complement System
Background:
- Human-pathogenic microbes employ diverse strategies to evade immune system destruction.
- A key strategy involves manipulating the host complement system, including binding complement inhibitors like factor H (FH).
- FH-related (FHR) proteins have also been observed to bind pathogens, but their role is increasingly understood as distinct from FH.
Purpose of the Study:
- To review the role of factor H (FH) in host-pathogen interactions.
- To highlight the emerging understanding of FH-related (FHR) proteins in complement activation during infection.
- To elucidate how pathogens exploit complement regulators for immune evasion.
Main Methods:
- Literature review of studies on complement system evasion by pathogens.
- Analysis of research on factor H (FH) and FH-related (FHR) protein interactions with microbial surfaces.
- Synthesis of current evidence on the regulatory functions of FH and FHR proteins in host-pathogen contexts.
Main Results:
- Pathogens bind host factor H (FH) to downregulate complement activity on their surface.
- FH-related (FHR) proteins, initially thought to be inhibitors, may instead enhance complement activation.
- FHR proteins can compete with FH for ligand binding and directly promote complement cascades.
Conclusions:
- Factor H (FH) is a critical target for microbial immune evasion strategies.
- FH-related (FHR) proteins represent a potentially significant, yet underappreciated, factor in complement-mediated host-pathogen dynamics.
- Understanding FHR protein function is crucial for comprehending microbial pathogenesis and developing new therapeutic approaches.
Related Concept Videos
Complement System
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Molecular Chaperones and Protein Folding
The...

